CEBP  Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

Cancer Epidemiology Biomarkers & Prevention 10, -, , . doi:
© 2008 American Association for Cancer Research

Right arrow Return to article

Table 5 Frequency of exposure to fumigants: individual compounds

Individual compounds+ NHL n = 517

Controls n = 1506

ORa (95% CI) ORadjb (95% CI)
n exposed % exposed n exposed % exposed

Malathionc 12 2.3 23 1.5 1.49 (0.72–3.11) 1.54 (0.74–3.22)
Carbon tetrachlorided 13 2.5 18 1.2 2.13 (1.02–4.47) 2.42 (1.19–5.14)

a ORs calculated with strata for the variables age and province of residence.

b ORs adjusted for statistically significant medical variables (history of measles, mumps, cancer, allergy desensitization shots, and a positive family history of cancer in a first-degree relative) and with strata for the variables age and province of residence.

c Malathion is an organophosphorus insecticide which has been used indoors as a fumigant.

d Carbon tetrachloride was used as a grain fumigant.





Right arrow Return to article


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation